<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Immunome Research - Latest articles</title>
		<link>http://www.immunome-research.com</link>
		<description>The latest articles from Immunome Research (ISSN 1745-7580) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.immunome-research.com/content/4/1/5"/>			    
            
				    <rdf:li rdf:resource="http://www.immunome-research.com/content/4/1/4"/>			    
            
				    <rdf:li rdf:resource="http://www.immunome-research.com/content/4/1/3"/>			    
            
				    <rdf:li rdf:resource="http://www.immunome-research.com/content/4/1/2"/>			    
            
				    <rdf:li rdf:resource="http://www.immunome-research.com/content/4/1/1"/>			    
            
				    <rdf:li rdf:resource="http://www.immunome-research.com/content/3/1/10"/>			    
            
				    <rdf:li rdf:resource="http://www.immunome-research.com/content/3/1/9"/>			    
            
				    <rdf:li rdf:resource="http://www.immunome-research.com/content/3/1/8"/>			    
            
				    <rdf:li rdf:resource="http://www.immunome-research.com/content/3/1/7"/>			    
            
				    <rdf:li rdf:resource="http://www.immunome-research.com/content/3/1/6"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.immunome-research.com/content/4/1/5">
            
            <title>Expression analysis of G Protein-Coupled Receptors in mouse macrophages</title>
			<description>Background:
Monocytes and macrophages express an extensive repertoire of G Protein-Coupled Receptors (GPCRs) that regulate inflammation and immunity. In this study we performed a systematic micro-array analysis of GPCR expression in primary mouse macrophages to identify family members that are either enriched in macrophages compared to a panel of other cell types, or are regulated by an inflammatory stimulus, the bacterial product lipopolysaccharide (LPS).
Results:
Several members of the P2RY family had striking expression patterns in macrophages; P2ry6 mRNA was essentially expressed in a macrophage-specific fashion, whilst P2ry1 and P2ry5 mRNA levels were strongly down-regulated by LPS. Expression of several other GPCRs was either restricted to macrophages (e.g. Gpr84) or to both macrophages and neural tissues (e.g. P2ry12, Gpr85). The GPCR repertoire expressed by bone marrow-derived macrophages and thioglycollate-elicited peritoneal macrophages had some commonality, but there were also several GPCRs preferentially expressed by either cell population.
Conclusion:
The constitutive or regulated expression in macrophages of several GPCRs identified in this study has not previously been described. Future studies on such GPCRs and their agonists are likely to provide important insights into macrophage biology, as well as novel inflammatory pathways that could be future targets for drug discovery.</description>
			<link>http://www.immunome-research.com/content/4/1/5</link>
			
			 	<dc:creator>Jane E Lattin, Kate Schroder, Andrew I Su, John R Walker, Jie Zhang, Tim Wiltshire, Kaoru Saijo, Christopher K Glass, David A Hume, Stuart Kellie and Matthew J Sweet</dc:creator>
			
			<dc:source>Immunome Research 2008, 4:5</dc:source>
			<dc:date>2008-04-29</dc:date>
			<dc:identifier>doi:10.1186/1745-7580-4-5</dc:identifier>
			
			
							
					<prism:publicationName>Immunome Research</prism:publicationName>
					
			
							
					<prism:issn>1745-7580</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>5</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.immunome-research.com/content/4/1/4">
            
            <title>Efficiency of the immunome protein interaction network increases during evolution</title>
			<description>Background:
Details of the mechanisms and selection pressures that shape the emergence and development of complex biological systems, such as the human immune system, are poorly understood. A recent definition of a reference set of proteins essential for the human immunome, combined with information about protein interaction networks for these proteins, facilitates evolutionary study of this biological machinery.
Results:
Here, we present a detailed study of the development of the immunome protein interaction network during eight evolutionary steps from Bilateria ancestors to human. New nodes show preferential attachment to high degree proteins. The efficiency of the immunome protein interaction network increases during the evolutionary steps, whereas the vulnerability of the network decreases.
Conclusion:
Our results shed light on selective forces acting on the emergence of biological networks. It is likely that the high efficiency and low vulnerability are intrinsic properties of many biological networks, which arise from the effects of evolutionary processes yet to be uncovered.</description>
			<link>http://www.immunome-research.com/content/4/1/4</link>
			
			 	<dc:creator>Csaba Ortutay and Mauno Vihinen</dc:creator>
			
			<dc:source>Immunome Research 2008, 4:4</dc:source>
			<dc:date>2008-04-22</dc:date>
			<dc:identifier>doi:10.1186/1745-7580-4-4</dc:identifier>
			
			
							
					<prism:publicationName>Immunome Research</prism:publicationName>
					
			
							
					<prism:issn>1745-7580</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>4</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.immunome-research.com/content/4/1/3">
            
            <title>Large-scale analysis of human heavy chain V(D)J recombination patterns</title>
			<description>Background:
The processes involved in the somatic assembly of antigen receptor genes are unique to the immune system and are driven largely by random events. Subtle biases, however, may exist and provide clues to the molecular mechanisms involved in their assembly and selection. Large-scale efforts to provide baseline data about the genetic characteristics of immunoglobulin (Ig) genes and the mechanisms involved in their assembly have recently become possible due to the rapid growth of genetic databases.
Results:
We gathered and analyzed nearly 6,500 productive human Ig heavy chain genes and compared them with 325 non-productive Ig genes that were originally rearranged out of frame and therefore incapable of being biased by selection. We found evidence for differences in n-nucleotide tract length distributions which have interesting interpretations for the mechanisms involved in n-nucleotide polymerization. Additionally, we found striking statistical evidence for pairing preferences among D and J segments. We present a statistical model to support our hypothesis that these pairing biases are due to multiple sequential D-to-J rearrangements.
Conclusion:
We present here the most precise estimates of gene segment usage frequencies currently available along with analyses regarding n-nucleotide distributions and D-J segment pair preferences. Additionally, we provide the first statistical evidence that sequential D-J recombinations occur at the human heavy chain locus during B-cell ontogeny with an approximate frequency of 20%.</description>
			<link>http://www.immunome-research.com/content/4/1/3</link>
			
			 	<dc:creator>Joseph M Volpe and Thomas B Kepler</dc:creator>
			
			<dc:source>Immunome Research 2008, 4:3</dc:source>
			<dc:date>2008-02-27</dc:date>
			<dc:identifier>doi:10.1186/1745-7580-4-3</dc:identifier>
			
			
							
					<prism:publicationName>Immunome Research</prism:publicationName>
					
			
							
					<prism:issn>1745-7580</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>3</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-27</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.immunome-research.com/content/4/1/2">
            
            <title>Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries</title>
			<description>Background:
It has been previously shown that combinatorial peptide libraries are a useful tool to characterize the binding specificity of class I MHC molecules. Compared to other methodologies, such as pool sequencing or measuring the affinities of individual peptides, utilizing positional scanning combinatorial libraries provides a baseline characterization of MHC molecular specificity that is cost effective, quantitative and unbiased.
Results:
Here, we present a large-scale application of this technology to 19 different human and mouse class I alleles. These include very well characterized alleles (e.g. HLA A*0201), alleles with little previous data available (e.g. HLA A*3201), and alleles with conflicting previous reports on specificity (e.g. HLA A*3001). For all alleles, the positional scanning combinatorial libraries were able to elucidate distinct binding patterns defined with a uniform approach, which we make available here. We introduce a heuristic method to translate this data into classical definitions of main and secondary anchor positions and their preferred residues. Finally, we validate that these matrices can be used to identify candidate MHC binding peptides and T cell epitopes in the vaccinia virus and influenza virus systems, respectively.
Conclusion:
These data confirm, on a large scale, including 15 human and 4 mouse class I alleles, the efficacy of the positional scanning combinatorial library approach for describing MHC class I binding specificity and identifying high affinity binding peptides. These libraries were shown to be useful for identifying specific primary and secondary anchor positions, and thereby simpler motifs, analogous to those described by other approaches. The present study also provides matrices useful for predicting high affinity binders for several alleles for which detailed quantitative descriptions of binding specificity were previously unavailable, including A*3001, A*3201, B*0801, B*1501 and B*1503.</description>
			<link>http://www.immunome-research.com/content/4/1/2</link>
			
			 	<dc:creator>John Sidney, Erika Assarsson, Carrie Moore, Sandy Ngo, Clemencia Pinilla, Alessandro Sette and Bjoern Peters</dc:creator>
			
			<dc:source>Immunome Research 2008, 4:2</dc:source>
			<dc:date>2008-01-25</dc:date>
			<dc:identifier>doi:10.1186/1745-7580-4-2</dc:identifier>
			
			
							
					<prism:publicationName>Immunome Research</prism:publicationName>
					
			
							
					<prism:issn>1745-7580</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>2</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-25</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.immunome-research.com/content/4/1/1">
            
            <title>Analysis and prediction of protective continuous B-cell epitopes on pathogen proteins</title>
			<description>Background:
The application of peptide based diagnostics and therapeutics mimicking part of protein antigen is experiencing renewed interest. So far selection and design rationale for such peptides is usually driven by T-cell epitope prediction, available experimental and modelled 3D structure, B-cell epitope predictions such as hydrophilicity plots or experience. If no structure is available the rational selection of peptides for the production of functionally altering or neutralizing antibodies is practically impossible. Specifically if many alternative antigens are available the reduction of required synthesized peptides until one successful candidate is found is of central technical interest. We have investigated the integration of B-cell epitope prediction with the variability of antigen and the conservation of patterns for post-translational modification (PTM) prediction to improve over state of the art in the field. In particular the application of machine-learning methods shows promising results.
Results:
We find that protein regions leading to the production of functionally altering antibodies are often characterized by a distinct increase in the cumulative sum of three presented parameters. Furthermore the concept to maximize antigenicity, minimize variability and minimize the likelihood of post-translational modification for the identification of relevant sites leads to biologically interesting observations. Primarily, for about 50% of antigen the approach works well with individual area under the ROC curve (AROC) values of at least 0.65. On the other hand a significant portion reveals equivalently low AROC values of &lt; = 0.35 indicating an overall non-Gaussian distribution. While about a third of 57 antigens are seemingly intangible by our approach our results suggest the existence of at least two distinct classes of bioinformatically detectable epitopes which should be predicted separately. As a side effect of our study we present a hand curated dataset for the validation of protectivity classification. Based on this dataset machine-learning methods further improve predictive power to a class separation in an equilibrated dataset of up to 83%.
Conclusion:
We present a computational method to automatically select and rank peptides for the stimulation of potentially protective or otherwise functionally altering antibodies. It can be shown that integration of variability, post-translational modification pattern conservation and B-cell antigenicity improve rational selection over random guessing. Probably more important, we find that for about 50% of antigen the approach works substantially better than for the overall dataset of 57 proteins. Essentially as a side effect our method optimizes for presumably best applicable peptides as they tend to be likely unmodified and as invariable as possible which is answering needs in diagnosis and treatment of pathogen infection. In addition we show the potential for further improvement by the application of machine-learning methods, in particular Random Forests.</description>
			<link>http://www.immunome-research.com/content/4/1/1</link>
			
			 	<dc:creator>Johannes Sollner, Rainer Grohmann, Ronald Rapberger, Paul Perco, Arno Lukas and Bernd Mayer</dc:creator>
			
			<dc:source>Immunome Research 2008, 4:1</dc:source>
			<dc:date>2008-01-07</dc:date>
			<dc:identifier>doi:10.1186/1745-7580-4-1</dc:identifier>
			
			
							
					<prism:publicationName>Immunome Research</prism:publicationName>
					
			
							
					<prism:issn>1745-7580</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>1</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-07</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.immunome-research.com/content/3/1/10">
            
            <title>An analysis of the epitope knowledge related to Mycobacteria</title>
			<description>Background:
Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, remains a leading cause of infectious disease morbidity and mortality, and is responsible for more than 2 million deaths a year. Reports about extremely drug resistant (XDR) strains have further heightened the sense of urgency for the development of novel strategies to prevent and treat TB. Detailed knowledge of the epitopes recognized by immune responses can aid in vaccine and diagnostics development, and provides important tools for basic research. The analysis of epitope data corresponding to M. tuberculosis can also identify gaps in our knowledge, and suggest potential areas for further research and discovery. The Immune Epitope Database (IEDB) is compiled mainly from literature sources, and describes a broad array of source organisms, including M. tuberculosis and other Mycobacterial species.DescriptionA comprehensive analysis of IEDB data regarding the genus Mycobacteria was performed. The distribution of antibody/B cell and T cell epitopes was analyzed in terms of their associated recognition cell type effector function and chemical properties. The various species, strains and proteins which the epitope were derived, were also examined. Additional variables considered were the host in which the epitopes were defined, the specific TB disease state associated with epitope recognition, and the HLA associated with disease susceptibility and endemic regions were also scrutinized. Finally, based on these results, standardized reference datasets of mycobacterial epitopes were generated.
Conclusion:
All current TB-related epitope data was cataloged for the first time from the published literature. The resulting inventory of more than a thousand different epitopes should prove a useful tool for the broad scientific community. Knowledge gaps specific to TB epitope data were also identified. In summary, few non-peptidic or post-translationally modified epitopes have been defined. Most importantly epitopes have apparently been defined from only 7% of all ORFs, and the top 30 most frequently studied protein antigens contain 65% of the epitopes, leaving the majority of M. tuberculosis genome unexplored. A lack of information related to the specific strains from which epitopes are derived is also evident. Finally, the generation of reference lists of mycobacterial epitopes should also facilitate future vaccine and diagnostic research.</description>
			<link>http://www.immunome-research.com/content/3/1/10</link>
			
			 	<dc:creator>Martin J Blythe, Qing Zhang, Kerrie Vaughan, Romulo de Castro, Nima Salimi, Huynh-Hoa Bui, David M Lewinsohn, Joel D Ernst, Bjoern Peters and Alessandro Sette</dc:creator>
			
			<dc:source>Immunome Research 2007, 3:10</dc:source>
			<dc:date>2007-12-14</dc:date>
			<dc:identifier>doi:10.1186/1745-7580-3-10</dc:identifier>
			
			
							
					<prism:publicationName>Immunome Research</prism:publicationName>
					
			
							
					<prism:issn>1745-7580</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>10</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-12-14</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.immunome-research.com/content/3/1/9">
            
            <title>Amino acid biophysical properties in the statistical prediction of peptide-MHC class I binding</title>
			<description>Background:
A key step in the development of an adaptive immune response to pathogens or vaccines is the binding of short peptides to molecules of the Major Histocompatibility Complex (MHC) for presentation to T lymphocytes, which are thereby activated and differentiate into effector and memory cells. The rational design of vaccines consists in part in the identification of appropriate peptides to effect this process. There are several algorithms currently in use for making such predictions, but these are limited to a small number of MHC molecules and have good but imperfect prediction power.
Results:
We have undertaken an exploration of the power gained by taking advantage of a natural representation of the amino acids in terms of their biophysical properties. We used several well-known statistical classifiers using either a naive encoding of amino acids by name or an encoding by biophysical properties. In all cases, the encoding by biophysical properties leads to substantially lower misclassification error.
Conclusion:
Representation of amino acids using a few important bio-physio-chemical property provide a natural basis for representing peptides and greatly improves peptide-MHC class I binding prediction.</description>
			<link>http://www.immunome-research.com/content/3/1/9</link>
			
			 	<dc:creator>Surajit Ray and Thomas B Kepler</dc:creator>
			
			<dc:source>Immunome Research 2007, 3:9</dc:source>
			<dc:date>2007-10-29</dc:date>
			<dc:identifier>doi:10.1186/1745-7580-3-9</dc:identifier>
			
			
							
					<prism:publicationName>Immunome Research</prism:publicationName>
					
			
							
					<prism:issn>1745-7580</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>9</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-10-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.immunome-research.com/content/3/1/8">
            
            <title>Using the natural evolution of a rotavirus-specific human monoclonal antibody to predict the complex topography of a viral antigenic site</title>
			<description>Background:
Understanding the interaction between viral proteins and neutralizing antibodies at atomic resolution is hindered by a lack of experimentally solved complexes. Progress in computational docking has led to the prediction of increasingly high-quality model antibody-antigen complexes. The accuracy of atomic-level docking predictions is improved when integrated with experimental information and expert knowledge.
Methods:
Binding affinity data associated with somatic mutations of a rotavirus-specific human adult antibody (RV6-26) are used to filter potential docking orientations of an antibody homology model with respect to the rotavirus VP6 crystal structure. The antibody structure is used to probe the VP6 trimer for candidate interface residues.
Results:
Three conformational epitopes are proposed. These epitopes are candidate antigenic regions for site-directed mutagenesis of VP6, which will help further elucidate antigenic function. A pseudo-atomic resolution RV6-26 antibody-VP6 complex is proposed consistent with current experimental information.
Conclusion:
The use of mutagenesis constraints in docking calculations allows for the identification of a small number of alternative arrangements of the antigen-antibody interface. The mutagenesis information from the natural evolution of a neutralizing antibody can be used to discriminate between residue-scale models and create distance constraints for atomic-resolution docking. The integration of binding affinity data or other information with computation may be an advantageous approach to assist peptide engineering or therapeutic antibody design.</description>
			<link>http://www.immunome-research.com/content/3/1/8</link>
			
			 	<dc:creator>Brett A McKinney, Nicole L Kallewaard, James E Crowe and Jens Meiler</dc:creator>
			
			<dc:source>Immunome Research 2007, 3:8</dc:source>
			<dc:date>2007-09-18</dc:date>
			<dc:identifier>doi:10.1186/1745-7580-3-8</dc:identifier>
			
			
							
					<prism:publicationName>Immunome Research</prism:publicationName>
					
			
							
					<prism:issn>1745-7580</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>8</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-09-18</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.immunome-research.com/content/3/1/7">
            
            <title>In silico characterization of immunogenic epitopes presented by HLA-Cw*0401</title>
			<description>Background:
HLA-C locus products are poorly understood in part due to their low expression at the cell surface. Recent data indicate that these molecules serve as major restriction elements for human immunodeficiency virus type 1 (HIV-1) cytotoxic T lymphocyte (CTL) epitopes. We report here a structure-based technique for the prediction of peptides binding to Cw*0401. The models were rigorously trained, tested and validated using experimentally verified Cw*0401 binding and non-binding peptides obtained from biochemical studies. A new scoring scheme facilitates the identification of immunological hot spots within antigens, based on the sum of predicted binding energies of the top four binders within a window of 30 amino acids.
Results:
High predictivity is achieved when tested on the training (r2 = 0.88, s = 3.56 kJ/mol, q2 = 0.84, spress = 5.18 kJ/mol) and test (AROC = 0.93) datasets. Characterization of the predicted Cw*0401 binding sequences indicate that amino acids at key anchor positions share common physico-chemical properties which correlate well with existing experimental studies.
Conclusion:
The analysis of predicted Cw*0401-binding peptides showed that anchor residues may not be restrictive and the Cw*0401 binding pockets may possibly accommodate a wide variety of peptides with common physico-chemical properties. The potential Cw*0401-specific T-cell epitope repertoires for HIV-1 p24gag and gp160gag glycoproteins are well distributed throughout both glycoproteins, with thirteen and nine immunological hot spots for HIV-1 p24gag and gp160gag glycoproteins respectively. These findings provide new insights into HLA-C peptide selectivity, indicating that pre-selection of candidate HLA-C peptides may occur at the TAP level, prior to peptide loading in the endoplasmic reticulum.</description>
			<link>http://www.immunome-research.com/content/3/1/7</link>
			
			 	<dc:creator>Joo Chuan Tong, Zong Hong Zhang, J Thomas August, Vladimir Brusic, Tin Wee Tan and Shoba Ranganathan</dc:creator>
			
			<dc:source>Immunome Research 2007, 3:7</dc:source>
			<dc:date>2007-08-20</dc:date>
			<dc:identifier>doi:10.1186/1745-7580-3-7</dc:identifier>
			
			
							
					<prism:publicationName>Immunome Research</prism:publicationName>
					
			
							
					<prism:issn>1745-7580</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>7</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-08-20</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.immunome-research.com/content/3/1/6">
            
            <title>IDR knowledge base for primary immunodeficiencies</title>
			<description>Background:
The ImmunoDeficiency Resource (IDR) is a knowledge base for the integration of the clinical, biochemical, genetic, genomic, proteomic, structural, and computational data of primary immunodeficiencies. The need for the IDR arises from the lack of structured and systematic information about primary immunodeficiencies on the Internet, and from the lack of a common platform which enables doctors, researchers, students, nurses and patients to find out validated information about these diseases.DescriptionThe IDR knowledge base, first released in 1999, has grown substantially. It contains information for 158 diseases, both from a clinical as well as molecular point of view. The database and the user interface have been reformatted. This new IDR release has a richer and more complete breadth, depth and scope. The service provides the most complete and up-to-date dataset. The IDR has been integrated with several internal and external databases and services. The contents of the IDR are validated and selected for different types of users (doctors, nurses, researchers and students, as well as patients and their families). The search engine has been improved and allows either a detailed or a broad search from a simple user interface.
Conclusion:
The IDR is the first knowledge base specifically designed to capture in a systematic and validated way both clinical and molecular information for primary immunodeficiencies. The service is freely available at http://bioinf.uta.fi/idr and is regularly updated. The IDR facilitates primary immunodeficiencies informatics and helps to parameterise in silico modelling of these diseases. The IDR is useful also as an advanced education tool for medical students, and physicians.</description>
			<link>http://www.immunome-research.com/content/3/1/6</link>
			
			 	<dc:creator>Crina Samarghitean, Jouni V&#228;liaho and Mauno Vihinen</dc:creator>
			
			<dc:source>Immunome Research 2007, 3:6</dc:source>
			<dc:date>2007-03-29</dc:date>
			<dc:identifier>doi:10.1186/1745-7580-3-6</dc:identifier>
			
			
							
					<prism:publicationName>Immunome Research</prism:publicationName>
					
			
							
					<prism:issn>1745-7580</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>6</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-03-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
